Intuitive Ventures logo

Intuitive Ventures

North America, California, United States, Sunnyvale

Description

Intuitive Ventures focuses on early-stage start-ups and takes a long-term outlook to support companies to reach their major milestones.

Investor Profile

Intuitive Ventures has made 14 investments, with 4 in the past 12 months and 29% as lead.

Stage Focus

  • Series B (29%)
  • Series A (29%)
  • Series C (21%)
  • Series D (14%)
  • Seed (7%)

Country Focus

  • United States (86%)
  • United Kingdom (14%)

Industry Focus

  • Health Care
  • Medical Device
  • Software
  • Biotechnology
  • Life Science
  • Analytics
  • Cloud Data Services
  • Cloud Management
  • Data Management
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Intuitive Ventures frequently co-invest with?

Great North Ventures
North America, Minnesota, United States, Maple Grove
Co-Investments: 2
Camford Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Sante Ventures
North America, Texas, United States, Austin
Co-Investments: 3
8VC
North America, California, United States, San Francisco
Co-Investments: 5
Beringea
North America, Michigan, United States, Farmington Hills
Co-Investments: 2
iSelect Fund
North America, Missouri, United States, St Louis
Co-Investments: 2
Pitango VC
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Cancer Research Institute
North America, New York, United States, New York
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 4
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Intuitive Ventures often collaborate with?

FM
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Intuitive Ventures?

Capstan Medical

Santa Cruz, California, United States

Capstan Medical is creating minimally invasive technologies to treat heart valve disorders.

MedicalMedical DeviceRobotics
Series CDec 11, 2024
Amount Raised: $110,000,000
XII Medical

Union City, California, United States

XII Medical provides minimally invasive technology for obstructive sleep apnea.

Health CareMedical DeviceWellness
Series BAug 21, 2024
Amount Raised: $45,000,000
Endogenex

Plymouth, Minnesota, United States

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels.

Health CareMedical DeviceTherapeutics
Series CJun 25, 2024
Amount Raised: $88,000,000
Amber Therapeutics

London, England, United Kingdom

Amber Therapeutics develops the next-generation of bioelectrical therapies.

BiotechnologyTherapeutics
Series AJun 10, 2024
Amount Raised: $101,703,017
Capstan Medical

Santa Cruz, California, United States

Capstan Medical is creating minimally invasive technologies to treat heart valve disorders.

MedicalMedical Device
Series BAug 9, 2023
Amount Raised: $31,400,000
SURGE Therapeutics

Cambridge, Massachusetts, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

BiotechnologyHealth CareLife Science
Series BJul 19, 2023
Amount Raised: $32,000,000
Flywheel.io

Minneapolis, Minnesota, United States

Flywheel.io is a data management and analysis platform built specifically for scientists and the researcher's workflow.

AnalyticsCloud Data ServicesCloud ManagementData ManagementSoftware
Series DJun 3, 2023
Amount Raised: $54,000,000
MedCrypt

Solana Beach, California, United States

MedCrypt is a medical device company that provides data security as a service to medical device OEMs.

Health CareMedical DeviceSecurity
Series BNov 1, 2022
Amount Raised: $25,000,000
Neocis

Miami, Florida, United States

Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics.

DentalHealth CareMedical DeviceRobotics
Series DOct 27, 2022
Amount Raised: $40,000,000
SURGE Therapeutics

Cambridge, Massachusetts, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

BiotechnologyHealth CareLife Science
Series AOct 17, 2022
Amount Raised: $26,000,000